Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and metabolic reprogramming

Platinum drug treatment is one of the most predominant chemotherapeutic strategies for patients with gastric cancer (GC). However, the therapeutic effect is less than satisfactory, largely due to the acquired resistance to platinum drugs. Therefore, a better understanding of the underlying mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Yi, Li, Fan, Jiao, Yuwen, Wang, Guoguang, Zhan, Tian, Xia, Yunwei, Liu, Hanyang, Yang, Haojun, Zhang, Jianping, Tang, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196146/
https://www.ncbi.nlm.nih.gov/pubmed/34117210
http://dx.doi.org/10.1038/s41420-021-00517-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196146/
https://www.ncbi.nlm.nih.gov/pubmed/34117210
http://dx.doi.org/10.1038/s41420-021-00517-w

Ejemplares similares